10 Milestones for Spine Devices & Companies FeaturedWritten by Laura Miller | August 24, 2012
Here are 10 milestones for spine devices and spinal implant companies.
Bonovo Orthopedics launched its PEEK lateral interbody fusion cage Cross-Fuse in China, which is designed for minimally invasive surgery to treat lumbar degenerative disease.
DePuy Synthes Spine has received FDA clearance for the use of its EXPEDIUM, VIPER and VIPER2 Spine Systems on patients with adolescent idiopathic scoliosis, which clears the devices to be used in posterior non-cervical pedicle screw fixation in adolescent patients.
Spine device company K2M has partnered with Cadwell Laboratories to provide a neuromonitoring solution for its RAVINE Lateral Access System.
Lanx was granted a patent for its ASPEN MIS Fusion System technology for spinal fusions, designed to be rigidly affixed to the spinous process with the use of streamlined surgical instrumentation.
Life Spine has been awarded its fourth patent for its AILERON Posterior Fusion System product family, designed for a flexible and rapid in-situ distraction for a custom anatomical fit for patients and to reduce overall procedure times.
Mazor Robotics, a company focused on robotic technology for spine surgery, has entered into an agreement with its investors regarding a private equity placement transaction of up to $15 million to provide further investment capital and place its share on the U.S. stock exchange.
Surgical device company Misonix has added six regional spine surgery sales organizations to market its BoneScalpel Ultrasonic Bone Cutting System.
Spine technology company Spinal Elements launched its Lucent Ti-Bond line of PEEK interbody implants with a plasma-sprayed titanium coating.
Privately held medical device company TransCorp Spine, received a methods patent for SpinePort MIS Access System, which is used for minimally invasive spinal decompressions and other types of procedures.
A study completed by TranS1 comparing its AxiaLIF pre-sacral interbody fusion to anterior lumbar interbody fusion in 96 patients shows that AxiaLIF has improved fusion rates and there were no serious adverse events with AxiaLIF.
More Articles on Spine Devices:
Globus Medical 2Q Sales Climb 18.6% to $96M
6 Things to Know About the Spine Market
Medtronic Spine Revenue Drops 5% This Quarter
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.